Revenue Breakdown
Composition ()
No data
Revenue Streams
ASP Isotopes Inc (ASPI) generates its revenue through a diversified portfolio of business segments. Currently, the largest contributor to its top-line growth is Construction services, accounting for 74.0% of total sales, equivalent to $3.62M. Another important revenue stream is Specialist isotopes and related services. Understanding this composition is critical for investors evaluating how ASPI navigates market cycles within the Pharmaceuticals industry.
Profitability & Margins
Evaluating the bottom line, ASP Isotopes Inc maintains a gross margin of 8.65%. This metric reflects the company's pricing power and manufacturing efficiency. Further down the income statement, the operating margin stands at -306.10%, while the net margin is -263.70%. These profitability ratios, combined with a Return on Equity (ROE) of -187.23%, provide a clear picture of how effectively ASPI converts its operational activities into shareholder value.
Comparative Benchmarking
In the context of the broader market, ASPI competes directly with industry leaders such as PHAT and CMPX. With a market capitalization of $828.23M, it holds a significant position in the sector. When comparing efficiency, ASPI's gross margin of 8.65% stands against PHAT's 87.50% and CMPX's N/A. Such benchmarking helps identify whether ASP Isotopes Inc is trading at a premium or discount relative to its financial performance.
